Home › Kanser sa Pantog › Texas › Austin

Pag-aaral pangklinika para sa Kanser sa Pantog sa Austin, TX

Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Nagre-recruitPhase 3

Texas Oncology, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07566156

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2

Texas Oncology - Central/South Texas, Austin
Texas Oncology - Central/South Texas, Austin
Texas Oncology - Central/South Texas, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3

USO-Texas Oncology-Central/South Texas, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07218380

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Nagre-recruitPhase 3

Urology Austin, LLC, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07480356

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Nagre-recruitPhase 2

Texas Oncology-Austin Central ( Site 0107), Austin
Urology Austin, PLLC ( Site 0109), Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06833073

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Nagre-recruitPhase 1/2

Texas Oncology (Balcones) - SCRI, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Nagre-recruitPhase 2

Urology Austin, PLLC (Urology America), Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Nagre-recruitPhase 2

Urology Austin, LLC, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Nagre-recruitPhase 1/2

Urology Austin, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Nagre-recruitPhase 2/3

Local Institution - 0187, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07106762

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Nagre-recruit

Austin Urology Institute, Austin

Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06394869

Pag-aaral para sa Kanser sa Pantog sa ibang lungsod

Iba pang pag-aaral sa Austin

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.